AMG 745 in Subjects With Age-associated Muscle Loss

Stopped Amgen has chosen at this time not to continue with AMG 745 study 20080733

Conditions

• Age-associated Muscle Loss

Interventions

• DRUG: AMG 745 0.3 mg/kg
• DRUG: AMG 745 1.0 mg/kg
• DRUG: AMG 745 3.0 mg/kg
• DRUG: Placebo

Sponsor

Amgen